(Q44865464)

6 December 2017

title

Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination (English)

1 reference

6 December 2017

0 references

0 references

0 references

1

1 reference

6 December 2017

2

B R Martin

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Pharmacology, Biochemistry and Behavior

6 December 2017

published in

1 reference

6 December 2017

volume

64

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

519-522

1 reference

Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

The benzodiazepine receptor antagonist, flumazenil does not block clinical effects of delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

The role of benzodiazepine receptors in the discriminative stimulus properties of delta-9-tetrahydrocannabinol.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

Gabaergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by Δ9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900130-6

7 January 2021

10.1016/S0091-3057(99)00130-6

Identifiers

DOI

1 reference

6 December 2017

1 reference